BW Communities

author-image

Shivam Tyagi

Author

The author works as a Correspondent with BW Businessworld

Latest Articles By Shivam Tyagi

Alembic Pharma's Revenue At Rs 1,437 Cr In Q2FY23, PAT Drops by 22%

Alembic pharmaceuticals registered a 12.3 per cent rise in its consolidated revenues quarter on quarter, with the company's revenue for the second quarter standing at Rs 1,437.34 crores against Rs 1,313.19 crores in the same quarter last year

Read More
IPCA Laboratories Profit Dips By 35%, Revenue At Rs 1637 Cr In Q2FY23

IPCA Laboratories registered a drop of 35 per cent in its net profits quarter on quarter, with the company's net profit for the second quarter at Rs 167.7 crores against Rs 257.6 crores in the same quarter last year

Read More
Q2 Results: Apollo Hospitals Net Profit Drops By 21.47% QoQ, Revenue At Rs 4,251.1 Cr

Apollo Hospitals in the second quarter has reported a dip of 21.47 per cent in its net profit of Rs 204 crores against its net profit of Rs 247.8 crores in the corresponding quarter last year

Read More
Q2 Results: Zydus Lifesciences Net Profit Slumps By 82.5% QoQ, Revenue At Rs 4,134.7 Cr

Zydus Lifesciences net profit for the quarter was recorded at Rs 522.5 crores against Rs 3,002 crores registered in the second quarter of the last year

Read More
Lupin Records Minimal Rise In Revenue, PAT At Rs 134.5 Cr In Q2FY23

Lupin pharma has posted a net profit of Rs 134.5 crores in quarter two of the fiscal year 2023, compared with a loss of 2,094.9 crores in the corresponding quarter last year

Read More
Q2 Results: Dr Lal PathLabs Reports 24.8% Drop In Net Profit, Consolidated Revenue At Rs 534 Cr

The diagnostic company has posted a 24.8% per cent drop in its net profit of Rs 72.4 crores for Quarter Two of the Financial Year 2022 (Q2FY22), from Rs 96.3 crores that the company secured in the same quarter last year

Read More
Divi's Labs Reports 18% Dip In Net Profit For The Sept Quarter, Consolidated Income At Rs 1,935 Cr

The company also registered an 18.48 per cent drop in its net profit in the second quarter to be recorded at Rs 494 crores as against its earnings in the same quarter last year which stood at Rs 606 crores

Read More
Q2 Results: Cipla Registers 5.7% Rise In Revenue, Reports PAT At Rs 789 Cr

The pharmaceutical company’s net profit also jumped by 10.91 per cent quarter on quarter in Q2FY22, the company recorded a net profit of Rs 788.90 crores in the September quarter

Read More
Rainbow Hospitals Reports 32% Rise In Sales In Sept Quarter, PAT Recorded At 61.5 Cr

EBITDA earnings for Q2FY23 of the hospital also soared with a quarter-on-quarter increase of 34.99 per cent and stood at Rs 109.5 crores up from Rs 89.2 crores in the second quarter last year

Read More
Q2 Results: Sun Pharma Sales Up By 10% YoY, Records Net profit Of 2,262 Cr

The company’s sales in India saw a jump of 8.5 per cent to Rs 3,460 crore, a rise of 8.5 per cent against the second quarter of last year. At the same time, the sales in the US were up by 27.5 per cent quarter on quarter and stood at USD 200 million

Read More

Subscribe to our newsletter to get updates on our latest news